Ethnic differences in the formation of small LDL particles in Asians: A comparison of Koreans, Japanese and Mongolians

European Journal of Clinical Investigation

Volumn 34, Issue 11, 2004, Pages 738-746

  Anuurad, Erdembileg ^a   Shiwaku, K ^a   Enkhmaa, B ^a   Nogi, A ^a   Kitajima, K ^a   Yamasaki, M ^a   Yamane, Y ^a  

^a SHIMANE UNIVERSITY   (Japan)

Author keywords

Japanese; Koreans; LDL particle size; Mongolians; Obesity; Triglyceride

Indexed keywords

FATTY ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; ASIAN; BODY MASS; CARBOHYDRATE DIET; CARDIOVASCULAR RISK; CONTROLLED STUDY; FEMALE; HUMAN; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; JAPAN; KOREA; LIPOPROTEIN METABOLISM; MAJOR CLINICAL STUDY; MALE; MONGOLIA; OBESITY; PARTICLE SIZE; PRIORITY JOURNAL; RACE DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CHOLESTEROL; CHOLESTEROL, LDL; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INSULIN RESISTANCE; JAPAN; KOREA; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; MONGOLIA; PARTICLE SIZE; TRIGLYCERIDES;

EID: 8744286412     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2004.01413.x     Document Type: Article

References (45)

1. Western Pacific Region Health Databank, 2002 Revision. WHO.
2. Khoo KL, Tan H, Liew YM, Deslypere JP, Janus E. Lipids and coronary disease in Asia. Atherosclerosis 2003;169:1-10.
3. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
4. Seidell JC. Obesity, insulin resistance and diabetes - a worldwide epidemic. Br J Nutr 2000;83 (Suppl. 1):S5-8.
5. Report of a WHO Consultation. Obesity: Preventing and Managing the Global Endemic. Geneva: WHO Technical Report Series 894, 2000.
6. Austin MA, Breslow JL, Hennekens CH, Buring JE, Willett WC, Krauss RM. Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA 1988;260:1917-21.
7. Stampfer MJ, Krauss RM, Ma J, Blanche PJ, Holl LG, Sacks FM et al. A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction. JAMA 1996;276:882-8.
8. Gardner CD, Fortmann SP, Krauss RM. Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women. JAMA 1996;276:875-81.
9. Lamarche B, Tchernof A, Moorjani S, Cantin B, Dagenais GR, Lupien PJ et al. Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Quebec Cardiovascular Study. Circulation 1997;95:69-75.
10. Nigon F, Lesnik P, Rouis M, Chapman MJ. Discrete subspecies of human low density lipoproteins are heterogeneous in their interaction with the cellular LDL receptor. J Lipid Res 1991;32:1741-53.
11. de Graff J, Hak-Lemmers HL, Hectors MP, Demacker PN, Hendriks JC, Stalenhoef AF. Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects. Arterioscler Thromb 1991;11:298-306.
12. Chait A, Brazg RL, Tribble DL, Krauss RM. Susceptibility of small, dense, low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype, pattern B. Am J Med 1993;94:350-6.
13. Cho HK, Shin G, Ryu SK, Jang Y, Day SP, Stewart G et al. Regulation of small dense LDL concentration in Korean and Scottish men and women. Atherosclerosis 2002;164:187-93.
14. Koba S, Hirano T, Yoshino G, Sakai K, Sakaue T, Adachi M et al. Remarkably high prevalence of small dense low-density lipoprotein in Japanese men with coronary artery disease, irrespective of the presence of diabetes. Atherosclerosis 2002;160:249-56.
15. Koba S, Hirano T, Kondo T, Shibata M, Suzuki H, Murakami M et al. Significance of small dense low-density lipoproteins and other risk factors in patients with various types of coronary heart disease. Am Heart J 2002;144:1026-35.
16. Mykkanen L, Kuusisto J, Haffner SM, Laakso M, Austin MA. LDL size and risk of coronary heart disease in elderly men and women. Arterioscler Thromb Vasc Biol 1999;19:2742-8.
17. Keys A, Menotti A, Aravanis C, Blackburn H, Djordevic BS, Buzina R et al. The Seven Countries Study: 2289 deaths in 15 years. Prev Med 1984;13:141-54.
18. Shiwaku K, Hashimoto M, Kitajima K, Nogi A, Anuurad E, Enkhmaa B et al. Triglyceride levels are ethnic-specifically associated with an index of stearoyl-CoA desaturase activity and n-3 PUFA levels in Asians. J Lipid Res 2004;45:914-22.
19. Shiwaku K, Anuurad E, Enkhmaa B, Nogi A, Kitajima K, Shimono K et al. Overweight Japanese with body mass indexes of 23.0-24.9 have higher risks for obesity-associated disorders: a comparison of Japanese and Mongolians. Int J Obes Relat Metab Disord 2004;28:152-8.
20. Katoh T, Mano S, Ikuta T, Munkhbat B, Tounai K, Ando H et al. Genetic isolates in East Asia: a study of linkage disequilibrium in the X chromosome. Am J Hum Genet 2002;71:395-400.
21. Kim S, Moon S, Popkin BM. The nutrition transition in South Korea. Am J Clin Nutr 2000;71:44-53.
22. Nakamura M, Tajima S, Yoshiike N. Nutrient intake in Japanese adults - from The National Nutrition Survey 1995-99. J Nutr Sci Vitaminol 2002;48:433-41.
23. Gill M. Meat production in developing countries. Proc Nutr Soc 1999;58:371-6.
24. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
25. Havel RJ, Rapaport E. Management of primary hyperlipidemia. N Engl J Med 1995;332:1491-8.
26. M Dobiaova. Atherogenic index of plasma [log(triglycerides/ HDL-cholesterol)]: theoretical and practical implications. Clin Chem 2004;50:1113-5.
27. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-9.
28. Griffin BA, Caslake MJ, Yip B, Tait GW, Packard CJ, Shepherd J. Rapid isolation of low density lipoprotein (LDL) subfractions from plasma by density gradient ultracentrifugation. Atherosclerosis 1990;83:59-67.
29. Griffin BA, Freeman DJ, Tait GW, Thomson J, Caslake MJ, Packard CJ et al. Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subtractions: relative contribution of small, dense LDL to coronary heart disease risk. Atherosclerosis 1994;106:241-53.
30. Tan CE, Foster L, Caslake MJ, Bedford D, Watson TD, McConnell M et al. Relations between plasma lipids and postheparin plasma Upases and VLDL and LDL subfraction patterns in normolipemic men and women. Arterioscler Thromb Vasc Biol 1995;15:1839-48.
31. Witte DR, Taskinen MR, Perttunen-Nio H, Van Tol A, Livingstone S, Colhoun HM. Study of agreement between LDL size as measured by nuclear magnetic resonance and gradient gel electrophoresis. J Lipid Res 2004;45:1069-76.
32. Dormans TP, Swinkels DW, de Graaf J, Hendriks JC, Stalenhoef AF, Demacker PN. Single-spin density-gradient ultracentrifugation vs gradient gel electrophoresis: two methods for detecting low-density-lipoprotein heterogeneity compared. Clin Chem 1991;37:853-8.
33. Moon OR, Kim NS, Jang SM, Yoon TH, Kim SO. The relationship between body mass index and the prevalence of obesity-related diseases based on the 1995 National Health Interview Survey in Korea. Obes Rev 2002;3:191-6.
34. The Examination Committee of Criteria for 'Obesity Disease' in Japan, Japan Society for the Study of Obesity: New criteria for 'obesity disease' in Japan. Circ J 2002;66:987-92.
35. Komatsu F, Hasegawa K, Watanabe S, Kawabata T, Yanagisawa Y, Kaneko Y et al. Comparison of electrocardiogram findings and lifestyles between urbanized people and ger-living people in Ulaanbaatar, Mongolia. Atherosclerosis 2004;175:101-8.
36. Grundy SM. Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome. Am J Cardiol 1998;81:18B-25B.
37. Kwiterovich PO Jr. Clinical relevance of the biochemical, metabolic, and genetic factors that influence low-density lipoprotein heterogeneity. Am J Cardiol 2002;90:30i-47i.
38. Tan KC, Shiu SW, Chu BY. Roles of hepatic lipase and cholesteryl ester transfer protein in determining low density lipoprotein subfraction distribution in Chinese patients with non-insulin-dependent diabetes mellitus. Atherosclerosis 1999;145:273-8.
39. Winkler K, Konrad T, Fullert S, Friedrich I, Destani R, Baumstark MW et al. Pioglitazone reduces atherogenic dense LDL particles in nondiabetic patients with arterial hypertension: a double-blind, placebo-controlled study. Diabetes Care 2003;26:2588-94.
40. Parks EJ, Hellerstein MK. Carbohydrate-induced hypertriacylglycerolemia: historical perspective and review of biological mechanisms. Am J Clin Nutr 2000;71:412-33.
41. Hellerstein MK, Schwarz JM, Neese RA. Regulation of hepatic de novo lipogenesis in humans. Annu Rev Nutr 1996;16:523-57.
42. Schonfeld G. Changes in the composition of very low density lipoprotein during carbohydrate induction in man. J Lab Clin Med 1970;75:206-11.
43. Ginsberg HN, Le NA, Melish J, Steinberg D, Brown WV. Effect of a high carbohydrate diet on apoprotein-B catabolism in man. Metabolism 1981;30:347-53.
44. Humphries SE, Berglund L, Isasi CR, Otvos JD, Kaluski D, Deckelbaum RJ et al. Loci for CETP, LPL, LIPC, and APOC3 affect plasma lipoprotein size and sub-population distribution in Hispanic and non-Hispanic white subjects: the Columbia University BioMarkers Study. Nutr Metab Cardiovasc Dis 2002;12:163-72.
45. Carr MC, Brunzell JD, Deeb SS. Ethnic differences in hepatic lipase and HDL in Japanese, black, and white Americans: role of central obesity and LIPC polymorphisms. J Lipid Res 2004;45:466-73.